Boris C Bastian
Affiliation: Memorial Sloan-Kettering Cancer Center
- The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of originDavid C Whiteman
Cancer Control Group, Queensland Institute of Medical Research, Brisbane, QLD, Australia
Pigment Cell Melanoma Res 24:879-97. 2011..We integrate the evidence from these separate trajectories to catalog the emerging major categories of melanomas and conclude with important unanswered questions relating to the development of melanoma and its cells of origin...
- KIT as a therapeutic target in metastatic melanomaRichard D Carvajal
Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
JAMA 305:2327-34. 2011..We explored the effects of KIT inhibition using imatinib mesylate in this molecular subset of disease...
- Germline mutations in BAP1 predispose to melanocytic tumorsThomas Wiesner
Department of Dermatology, Medical University of Graz, Graz, Austria
Nat Genet 43:1018-21. 2011..These findings suggest that loss of BAP1 is associated with a clinically and morphologically distinct type of melanocytic neoplasm...